Alivus Life Sciences informs about press release

23 Jan 2025 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Alivus Life Sciences has informed that it enclosed the Press Release on the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

904.00 -1.40 (-0.15%)
26-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1503.00
Zydus Lifesciences 911.95
Lupin 2101.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×